Every company needs to go through this process.
Ask this question – has the overseas business been challenged?
Quality companies should welcome the challenge and prove themselves to overseas regulators.
Only if the company passes the test, the international story is fair and square.
PDD/Temu is going through this process; the challenge just came up around de minimis exemption.
CALT’s licensing agreements in the US is also being questioned to some extent.
Wuxi Bio is going through this process (US Biosecure Act) and hasn’t proved itself yet.
Beigene is being challenged over IP by Abbvie.
No need to mention ByteDance/TikTok.
etc.
Chinese companies need be prepared to fight uphill battles in overseas if they want the US market. Behaving better then a local company seems to be a minimum; be careful about anything that may seem “unfair” for overseas regulators.